{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:03:27Z","timestamp":1760979807618},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T00:00:00Z","timestamp":1098316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Breast cancer is the commonest cause of cancer death in women in the Western world, and imaging is essential in its diagnosis and staging. Metabolic imaging is a novel approach to improving the detection of cancers, as malignant transformation of cells is often associated with increased metabolic activity. This review assesses the possible role of positron emission tomography (PET) as a single non-invasive imaging modality to replace or complement current imaging and surgical practices in the diagnosis and staging of breast cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A Medline search was performed and articles were cross-referenced with other relevant material. Evaluation of primary breast cancer with PET has shown a sensitivity of between 64 and 100 per cent and a specificity of 33\u2013100 per cent; diagnostic accuracy appears to be related to tumour size. Difficulties arise in altered fluorodeoxyglucose uptake in lobular carcinoma, carcinoma in situ and benign inflammatory breast disease. In axillary staging, sensitivities of between 25 and 100 per cent have been reported, but with a false-negative of up to 20 per cent. In the assessment of distant metastasis and asymptomatic patients with raised levels of tumour markers, PET was superior to conventional imaging modalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PET is not a single diagnostic and staging tool that can replace current surgical, histological and radiological staging. Its main role in breast cancer lies in the investigation of metastatic disease and the evaluation of pathological response to various chemotherapeutic regimens.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs.4791","type":"journal-article","created":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T17:21:54Z","timestamp":1098379314000},"page":"1398-1409","source":"Crossref","is-referenced-by-count":27,"title":["Positron emission tomography in the staging and management of breast cancer"],"prefix":"10.1093","volume":"91","author":[{"given":"A M","family":"Byrne","sequence":"first","affiliation":[{"name":"Surgical Professorial Unit, St Vincent's University Hospital, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D K","family":"Hill","sequence":"additional","affiliation":[{"name":"Surgical Professorial Unit, St Vincent's University Hospital, Ireland"},{"name":"Conway Institute of Biomolecular and Biomedical Sciences, University College Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Skehan","sequence":"additional","affiliation":[{"name":"Department of Radiology, St Vincent's University Hospital, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E W","family":"McDermott","sequence":"additional","affiliation":[{"name":"Surgical Professorial Unit, St Vincent's University Hospital, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N J","family":"O'Higgins","sequence":"additional","affiliation":[{"name":"Surgical Professorial Unit, St Vincent's University Hospital, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,10,21]]},"reference":[{"key":"2021070907023402800_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"2021070907023402800_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/ejso.2001.1114","article-title":"Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team","volume":"27","author":"Rampaul","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"2021070907023402800_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1259\/bjr.70.835.9245877","article-title":"Positron emission tomography (PET) scanning in breast cancer","volume":"70","author":"Powe","year":"1997","journal-title":"Br J Radiol"},{"key":"2021070907023402800_bib4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1259\/bjr.72.863.10700822","article-title":"Positron emission tomography in breast cancer: a clinicopathological correlation of results","volume":"72","author":"Rostom","year":"1999","journal-title":"Br J Radiol"},{"key":"2021070907023402800_bib5","volume-title":"The Metabolism of Tumours","author":"Warburg","year":"1931"},{"key":"2021070907023402800_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0748-7983(98)80016-4","article-title":"Gamma emission imaging in the management of breast disorders","volume":"24","author":"Smith","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"2021070907023402800_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0720-048X(02)00003-7","article-title":"Positron emission tomography: a technical introduction for clinicians","volume":"44","author":"Blokland","year":"2002","journal-title":"Eur J Radiol"},{"key":"2021070907023402800_bib8","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","article-title":"Metabolic monitoring of breast cancer chemotherapy using positron emission tomography: initial evaluation","volume":"11","author":"Wahl","year":"1993","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"2021070907023402800_bib10","first-page":"670","article-title":"A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (F-18): non-toxic tracer for rapid tumour detection","volume":"21","author":"Som","year":"1980","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0936-6555(05)80033-0","article-title":"Positron emission tomography: a new investigational area for cancer research","volume":"8","author":"Wells","year":"1996","journal-title":"Clin Oncol"},{"key":"2021070907023402800_bib12","first-page":"925","article-title":"Experimental studies of 18F-2-deoxy-d-glucose in infection and in reactive lymph nodes","volume":"33","author":"Gutowski","year":"1992","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.19.1.g99ja0761","article-title":"Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants","volume":"19","author":"Shreve","year":"1999","journal-title":"Radiographics"},{"key":"2021070907023402800_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/93.8.630","article-title":"Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-d-glucose-positron emission tomography: clinical evaluation and alternative management","volume":"93","author":"Greco","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2021070907023402800_bib15","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/1097-0142(19930615)71:12<3920::AID-CNCR2820711220>3.0.CO;2-N","article-title":"Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer","volume":"71","author":"Nieweg","year":"1993","journal-title":"Cancer"},{"key":"2021070907023402800_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000658-199207000-00005","article-title":"The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease","volume":"216","author":"Tse","year":"1992","journal-title":"Ann Surg"},{"key":"2021070907023402800_bib17","first-page":"1238","article-title":"Pattern of uptake and excretion of 18F-FDG in the lactating breast","volume":"42","author":"Hicks","year":"2001","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.0007-1323.2002.02059.x","article-title":"Positron emission tomography for staging and management of malignant melanoma","volume":"89","author":"Prichard","year":"2002","journal-title":"Br J Surg"},{"key":"2021070907023402800_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00843701","article-title":"The usefulness of FDG positron emission tomography in the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography","volume":"23","author":"Sasaki","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"2021070907023402800_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02303744","article-title":"Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography","volume":"4","author":"Ogunbiyi","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"2021070907023402800_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000658-199803000-00001","article-title":"Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer","volume":"227","author":"Flanagan","year":"1998","journal-title":"Ann Surg"},{"key":"2021070907023402800_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00702620","article-title":"[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer","volume":"15","author":"Minn","year":"1989","journal-title":"Eur J Nuc Med"},{"key":"2021070907023402800_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.187.3.8497624","article-title":"Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-d-glucose PET","volume":"187","author":"Adler","year":"1993","journal-title":"Radiology"},{"key":"2021070907023402800_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00834522","article-title":"Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability","volume":"23","author":"Scheidhauer","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"2021070907023402800_bib25","first-page":"1766","article-title":"Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays","volume":"36","author":"Dehdashti","year":"1995","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00263811","article-title":"Carbon-11-labelled tyrosine to study tumor metabolism by positron emission tomography (PET)","volume":"12","author":"Bolster","year":"1986","journal-title":"Eur J Nucl Med"},{"key":"2021070907023402800_bib27","first-page":"1097","article-title":"Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography","volume":"13","author":"Kubota","year":"1989","journal-title":"J Comput Assist Tomogr"},{"key":"2021070907023402800_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1148\/radiology.179.3.2027989","article-title":"Primary and metastatic breast carcinoma: initial clinical evaluation with PET with radiolabeled glucose analogue 2-(F18)-fluoro-2-deoxy-d-glucose","volume":"179","author":"Wahl","year":"1991","journal-title":"Radiology"},{"key":"2021070907023402800_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1749-6632.1993.tb17236.x","article-title":"Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy","volume":"698","author":"Nieweg","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"2021070907023402800_bib30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00004728-199307000-00012","article-title":"Cancer detection with whole-body PET using 2-[18-F]fluoro-2-deoxy-d-glucose","volume":"17","author":"Hoh","year":"1993","journal-title":"J Comput Assist Tomogr"},{"key":"2021070907023402800_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0748-7983(95)91492-7","article-title":"Positron emission tomography: 2-deoxy-2-[18F]-fluoro-d-glucose uptake in locally advanced breast cancers","volume":"21","author":"Bruce","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"2021070907023402800_bib32","first-page":"931","article-title":"Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer","volume":"37","author":"Bassa","year":"1996","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib33","first-page":"693","article-title":"Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: can positron emission tomography (PET) with 18-F-FDG be considered as the best method?","volume":"8","author":"Bombardieri","year":"1996","journal-title":"Int J Oncol"},{"key":"2021070907023402800_bib34","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1996.14.6.1848","article-title":"Metabolic characteristics of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose","volume":"14","author":"Avril","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s002689900374","article-title":"Diagnostic value of positron emission tomography for detecting breast cancer","volume":"22","author":"Noh","year":"1998","journal-title":"World J Surg"},{"key":"2021070907023402800_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1095-0397(00)00050-9","article-title":"The potential of F-18-FDG PET in breast cancer: detection of primary lesions, axillary lymph node metastases, or distant metastases","volume":"3","author":"Hubner","year":"2000","journal-title":"Clin Pos Imag"},{"key":"2021070907023402800_bib37","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations","volume":"18","author":"Avril","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1259\/bjr.75.898.750789","article-title":"Pre-operative staging of invasive breast cancer with MR mammography and\/or PET: boon or bunk?","volume":"75","author":"Rieber","year":"2002","journal-title":"Br J Radiol"},{"key":"2021070907023402800_bib39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/crad.2001.0803","article-title":"Nuclear medicine in primary breast cancer imaging","volume":"57","author":"Gopalan","year":"2002","journal-title":"Clin Radiol"},{"key":"2021070907023402800_bib40","first-page":"4","article-title":"Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer","volume":"39","author":"Crippa","year":"1998","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiology.203.2.9114082","article-title":"Axillary lymph node metastases: Screening with [F-18]2-fluoro-deoxy-2-d-glucose (FDG) PET","volume":"203","author":"Adler","year":"1997","journal-title":"Radiology"},{"key":"2021070907023402800_bib42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1054\/bjoc.2000.1496","article-title":"Application of positron emission tomography to cancer screening","volume":"83","author":"Yasuda","year":"2000","journal-title":"Br J Cancer"},{"key":"2021070907023402800_bib43","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/1097-0142(19951101)76:9<1491::AID-CNCR2820760902>3.0.CO;2-8","article-title":"Axillary lymph nodes and breast cancer: a review","volume":"76","author":"Recht","year":"1995","journal-title":"Cancer"},{"key":"2021070907023402800_bib44","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/BF01249621","article-title":"Prospective evaluation of fluorine\u201318 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry","volume":"23","author":"Utech","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"2021070907023402800_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000658-199808000-00012","article-title":"Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-d-glucose","volume":"228","author":"Smith","year":"1998","journal-title":"Ann Surg"},{"key":"2021070907023402800_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002590000448","article-title":"Fluorine-18 2-deoxy-2-fluoro-d-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures","volume":"28","author":"Schirrmeister","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"2021070907023402800_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hye007","article-title":"Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients","volume":"31","author":"Yang","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"2021070907023402800_bib48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200211000-00012","article-title":"Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer","volume":"236","author":"van der Hoeven","year":"2002","journal-title":"Ann Surg"},{"key":"2021070907023402800_bib49","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1245\/ASO.2003.12.019","article-title":"Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer","volume":"10","author":"Barranger","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"2021070907023402800_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.2004.04.148","article-title":"Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group","volume":"22","author":"Wahl","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejso.2003.10.010","article-title":"18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer","volume":"30","author":"Zornoza","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"2021070907023402800_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02967197","article-title":"Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer","volume":"7","author":"Ohta","year":"2000","journal-title":"Breast Cancer"},{"key":"2021070907023402800_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0001-2998(98)80030-5","article-title":"PET instrumentation: what are the limits?","volume":"28","author":"Budinger","year":"1998","journal-title":"Semin Nucl Med"},{"key":"2021070907023402800_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.0007-1323.2001.01962.x","article-title":"Sentinel lymph node biopsy and breast cancer","volume":"89","author":"Noguchi","year":"2002","journal-title":"Br J Surg"},{"key":"2021070907023402800_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3816\/CBC.2002.n.014","article-title":"Positron emission tomography and sentinel lymph node dissection in breast cancer","volume":"3","author":"Kelemen","year":"2002","journal-title":"Clin Breast Cancer"},{"key":"2021070907023402800_bib56","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00006231-200209000-00009","article-title":"Comparison of fluorodeoxyglucose positron emission tomography and \u2018conventional diagnostic procedures\u2019 for the detection of distant metastases in breast cancer patients","volume":"23","author":"Dose","year":"2002","journal-title":"Nucl Med Commun"},{"key":"2021070907023402800_bib57","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00006231-200108000-00005","article-title":"Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy","volume":"22","author":"Ohta","year":"2001","journal-title":"Nucl Med Commun"},{"key":"2021070907023402800_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00432-002-0342-5","article-title":"Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer","volume":"128","author":"Yang","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021070907023402800_bib59","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00432-003-0424-z","article-title":"[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer","volume":"129","author":"Kamel","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021070907023402800_bib61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1076-6332(03)80461-0","article-title":"Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy","volume":"9","author":"Stafford","year":"2002","journal-title":"Acad Radiol"},{"key":"2021070907023402800_bib62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.1995.13.3.547","article-title":"Randomized trial of chemoendocrine therapy started before or after surgery for the treatment of primary breast cancer","volume":"13","author":"Powles","year":"1995","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib63","first-page":"493","article-title":"Role of multimodality therapy in the management of locally advanced carcinoma of the breast","volume":"179","author":"Heys","year":"1994","journal-title":"J Am Coll Surg"},{"key":"2021070907023402800_bib64","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","article-title":"Positron emission tomography using [18F]-fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer","volume":"18","author":"Schelling","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib65","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local\u2013regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib66","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0959-8049(97)00038-5","article-title":"Clinical and pathological response to primary chemotherapy in operable breast cancer","volume":"33","author":"Chollet","year":"1997","journal-title":"Eur J Cancer"},{"key":"2021070907023402800_bib67","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7863\/jum.1997.16.12.791","article-title":"Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer","volume":"16","author":"Yang","year":"1997","journal-title":"J Ultrasound Med"},{"key":"2021070907023402800_bib68","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.198.2.8596826","article-title":"Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy","volume":"198","author":"Helvie","year":"1996","journal-title":"Radiology"},{"key":"2021070907023402800_bib69","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1200\/JCO.2000.18.8.1676","article-title":"Positron emission tomography using [18F]-fluorodeoxy-d-glucose to predict the pathologic response of breast cancer to primary chemotherapy","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0959-8049(01)00379-3","article-title":"Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography","volume":"38","author":"Burcombe","year":"2002","journal-title":"Eur J Cancer"},{"key":"2021070907023402800_bib71","first-page":"1334","article-title":"Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective","volume":"42","author":"Yap","year":"2001","journal-title":"J Nucl Med"},{"key":"2021070907023402800_bib72","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2001.19.11.2797","article-title":"Metabolic flare: indicator of hormone responsiveness in advanced breast cancer","volume":"19","author":"Mortimer","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib73","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1097-0142(19930215)71:4<1266::AID-CNCR2820710416>3.0.CO;2-K","article-title":"Up-regulation of estrogen receptor by tamoxifen in human breast cancer","volume":"71","author":"Noguchi","year":"1993","journal-title":"Cancer"},{"key":"2021070907023402800_bib74","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.1996.14.7.2000","article-title":"Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase II trials","volume":"14","author":"Buzdar","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021070907023402800_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s002590050359","article-title":"Positron emission tomographic assessment of \u2018metabolic flare\u2019 to predict response of metastatic breast cancer to antiestrogen therapy","volume":"26","author":"Dehdashti","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"2021070907023402800_bib76","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/92.14.1143","article-title":"Long term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization of Research and Treatment of Cancer 10 801 trial","volume":"92","author":"van Dongan","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2021070907023402800_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00690183","article-title":"Use of serial carcinoembryonic antigen and CA 15\u00b73 assays in detecting relapses in breast cancer patients","volume":"36","author":"Molina","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"2021070907023402800_bib78","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jjco\/hyf052","article-title":"Clinical impact of [18F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report","volume":"32","author":"Liu","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"2021070907023402800_bib79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006231-199603000-00004","article-title":"FDG-PET screening for cerebral metastases in patients with suspected malignancy","volume":"17","author":"Larcos","year":"1996","journal-title":"Nucl Med Commun"},{"key":"2021070907023402800_bib80","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.bjc.6690074","article-title":"Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients","volume":"79","author":"Ahmad","year":"1999","journal-title":"Br J Cancer"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.4791","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/91\/11\/1398\/36728908\/bjs4791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/91\/11\/1398\/36728908\/bjs4791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T16:20:21Z","timestamp":1625847621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/91\/11\/1398\/6150707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,21]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2004,10,21]]},"published-print":{"date-parts":[[2004,10,21]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.4791","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,10,21]]}}}